What You Should Know:
- MEDITECH announces that Golden Valley Memorial Healthcare (GVMH) is their first client to go live on Expanse Genomics, opening the organization’s possibilities for delivering precision medicine by allowing them to analyze and parse genetic results into discrete, actionable data, displayed directly in patient charts.
- Providers can order genetic testing directly in Expanse, and the results will be received and stored in a codified format along with full PDF reports
Read More
Clinical Decision Support |Health IT | EMR/EHR | News, Analysis, Insights - HIT Consultant
Invitae Launches Genomics-Forward Digital Health Platform
What You Should Know:
- Invitae launches a seamless digital platform to enhance patient and provider experiences and further bring genetics to mainstream medicine.
- Offering seamless integrations with EHR solutions, Invitae Digital Health will provide healthcare systems with a customizable suite of tools in a single, intuitive platform.
Invitae, a San Francisco, CA, based medical genetics company, announced the launch of Invitae Digital Health—a connected
Read More
ConcertAI Raises $150M at $1.9 Billion Valuation for RWD Platform
What You Should Know:
- ConcertAI, LLC (ConcertAI), the leader in enterprise AI and real-world data (RWD) solutions for life sciences and healthcare, announced the close of its $150M in Series C led by Sixth Street at a $1.9B valuation.
- From its startup just five years ago, ConcertAI has emerged as one of the fastest-growing companies providing high-value software-as-a-service (SaaS) and data solutions to life sciences and biopharma companies, leading healthcare providers, contract
Read More
Antidote Health Secures $22M to Expand Telehealth Platform for Primary Care, Mental Health, Hypertension Care
What You Should Know:
- Antidote Health, an NYC-based telehealth provider announced it has raised $22M in Series A funding led by third-time investor iAngels, Group 11, and Flint Capital.
- The company will use the funds to support R&D activity, which includes advanced AI screening and clinical decision support system capabilities.
Quality healthcare doesn’t need to be expensive
Founded in 2020, Antidote Health democratizes access, delivering care for the whole family for a
Read More
Crisis in the U.S. Healthcare Workforce: Why It’s Time to introduce AI
One of the many acute challenges during the pandemic has been the departure of approximately 18% of the U.S. healthcare workforce,4 resulting in staffing shortages in hospitals. This has impacted the well-being of the remaining healthcare practitioners 5 as well as their patients – many of whom are deferring care that is vital to disease management and overall maintenance of health,6,7 or who do not have access to timely emergency care.1 Though such challenges may be perceived as insurmountable
Read More
Innovaccer, Roche Partner to Develop Clinical Decision Support Solutions
What You Should Know:
- Innovaccer Inc. the Health Cloud company, announced it has entered into a three-year collaboration with Roche to partner in the development of innovative clinical decision support solutions on the InnovaccerⓇ Health Cloud for the U.S. market.
- As part of the strategic collaboration, the Innovaccer Health Cloud and its core Data Activation Platform will be used to integrate disparate data from EHRs, labs, claims, pharmacy—virtually any healthcare data
Read More
Mayo Clinic, Verily Partner to Develop Clinical Decision Support Solutions
What You Should Know:
- Today, Mayo Clinic and Verily, an Alphabet company announced a strategic two-year collaboration to develop clinical decision support solutions. This modular, evidence-based decision support solution, will provide contextualized and validated knowledge on disease management, care guidelines, and treatment to help clinicians make decisions.
- The clinical decision support tool will be developed based on a broad range of health-relevant data sources, including
Read More
Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity
The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the course of the quarter, we observed $7 billion in private equity and venture capital investment across 158 companies.
By comparison, Q1 of 2020 saw $3.2 billion and 127 investments. Health IT
Read More
Key Lessons from COVID-19 & How We Can Better Support our Healthcare Provider
COVID-19 has been a novel pandemic in many ways beyond the actual virus itself – from the irreparable impacts it’s having on society, to the immense strain it’s put on the healthcare industry. A recent report stated that 93% of healthcare professionals reported experiencing stress, 86% reported experiencing anxiety, and 76% reported exhaustion and burnout [1]. Considering that the virus will continue to have an impact in 2021 and the reality that COVID-19 will likely not be the last epidemic we
Read More
NeoGenomics Acquires Precision Oncology Platform Trapelo Health for $65M
What You Should Know:
- NeoGenomics, Inc., a provider of cancer-focused genetic testing services and global oncology contract research services announced it has reached an agreement to acquire precision oncology platform Trapelo Health for $65M. The agreement purchase price of $65 million, consists of $35 million in cash on hand and $30 million in NeoGenomics common stock and is expected to close in April 2021.
- Trapelo Health offers a first-of-its-kind, interoperable, decision-support
Read More
